Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116191932 | 11619193 | 2 | F | 20160713 | 20151012 | 20160728 | PER | US-BAYER-2015-435928 | BAYER | 0.00 | F | Y | 83.45000 | KG | 20160728 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116191932 | 11619193 | 1 | PS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 19537 | TABLET | ||||||||||
| 116191932 | 11619193 | 2 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 19537 | TABLET | ||||||||||
| 116191932 | 11619193 | 3 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 19537 | TABLET | ||||||||||
| 116191932 | 11619193 | 4 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 19537 | TABLET | ||||||||||
| 116191932 | 11619193 | 5 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 19537 | TABLET | ||||||||||
| 116191932 | 11619193 | 6 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 19537 | TABLET | ||||||||||
| 116191932 | 11619193 | 7 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 19537 | TABLET | ||||||||||
| 116191932 | 11619193 | 8 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 19537 | TABLET | ||||||||||
| 116191932 | 11619193 | 9 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | UNK | 0 | FILM-COATED TABLET | ||||||||||
| 116191932 | 11619193 | 10 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | UNK | 0 | FILM-COATED TABLET | ||||||||||
| 116191932 | 11619193 | 11 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 0 | ||||||||||||
| 116191932 | 11619193 | 12 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 0 | ||||||||||||
| 116191932 | 11619193 | 13 | C | NAPROXEN. | NAPROXEN | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 14 | C | NAPROXEN. | NAPROXEN | 1 | 0 | ||||||||||||
| 116191932 | 11619193 | 15 | C | NEURONTIN | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 16 | C | COREG | CARVEDILOL | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 17 | C | AVALIDE | HYDROCHLOROTHIAZIDEIRBESARTAN | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 18 | C | PROCARDIA | NIFEDIPINE | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 19 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 20 | C | THEOPHYLLINE | THEOPHYLLINE ANHYDROUS | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 21 | C | DULOXETINE. | DULOXETINE | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 22 | C | CLOZAPINE. | CLOZAPINE | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 23 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 24 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 25 | C | TIZANIDINE. | TIZANIDINE | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 26 | C | METHOTREXATE. | METHOTREXATE | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 27 | C | CYCLOSPORINE. | CYCLOSPORINE | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 28 | C | WARFARIN | WARFARIN | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 29 | C | GLIBENCLAMIDE | GLYBURIDE | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 30 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 31 | C | ZETIA | EZETIMIBE | 1 | UNK | 0 | |||||||||||
| 116191932 | 11619193 | 32 | C | ROPINIROLE. | ROPINIROLE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116191932 | 11619193 | 11 | Pain |
| 116191932 | 11619193 | 12 | Depression |
| 116191932 | 11619193 | 13 | Depression |
| 116191932 | 11619193 | 14 | Pain |
| 116191932 | 11619193 | 15 | Pain |
| 116191932 | 11619193 | 16 | Cardiac disorder |
| 116191932 | 11619193 | 17 | Blood pressure measurement |
| 116191932 | 11619193 | 18 | Blood pressure measurement |
| 116191932 | 11619193 | 19 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116191932 | 11619193 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116191932 | 11619193 | Anxiety | |
| 116191932 | 11619193 | Emotional distress | |
| 116191932 | 11619193 | Hypoaesthesia | |
| 116191932 | 11619193 | Injury | |
| 116191932 | 11619193 | Neuropathy peripheral | |
| 116191932 | 11619193 | Pain | |
| 116191932 | 11619193 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116191932 | 11619193 | 1 | 200801 | 200804 | 0 | |
| 116191932 | 11619193 | 2 | 200810 | 200811 | 0 | |
| 116191932 | 11619193 | 3 | 2008 | 0 | ||
| 116191932 | 11619193 | 4 | 200904 | 200905 | 0 | |
| 116191932 | 11619193 | 5 | 201002 | 201009 | 0 | |
| 116191932 | 11619193 | 6 | 201206 | 201212 | 0 | |
| 116191932 | 11619193 | 7 | 201411 | 201501 | 0 | |
| 116191932 | 11619193 | 8 | 201602 | 201603 | 0 | |
| 116191932 | 11619193 | 9 | 20061227 | 20070103 | 0 | |
| 116191932 | 11619193 | 10 | 2008 | 0 | ||
| 116191932 | 11619193 | 13 | 201511 | 0 | ||
| 116191932 | 11619193 | 15 | 201411 | 0 | ||
| 116191932 | 11619193 | 16 | 201411 | 0 | ||
| 116191932 | 11619193 | 17 | 201604 | 0 | ||
| 116191932 | 11619193 | 18 | 201604 | 0 | ||
| 116191932 | 11619193 | 19 | 201603 | 0 | ||
| 116191932 | 11619193 | 30 | 201603 | 0 | ||
| 116191932 | 11619193 | 31 | 201603 | 0 |